First Time Loading...

M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 877.5 JPY -0.29%
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one M3 Inc stock under the Base Case scenario is 1 678.14 JPY. Compared to the current market price of 1 877.5 JPY, M3 Inc is Overvalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 678.14 JPY
Overvaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.4
P/S
P/S
Price to Sales
5.4
vs History
98
vs Industry
25
Median 3Y
12.3
Median 5Y
14.3
Industry
2.4
Forward
5.2
More Details
27.5
P/E
P/E
Price to Earnings
27.5
vs History
98
vs Industry
21
Median 3Y
46.4
Median 5Y
64.1
Industry
23.2
Forward
25.6
More Details
21.5
P/OCF
P/OCF
Price to OCF
21.5
vs History
98
vs Industry
20
Median 3Y
48.2
Median 5Y
71.1
Industry
15.5
More Details
20.5
P/FCFE
P/FCFE
Price to FCFE
20.5
vs History
98
vs Industry
25
Median 3Y
55.8
Median 5Y
84.6
Industry
23.5
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
98
vs Industry
23
Median 3Y
9.9
Median 5Y
11.7
Industry
2.2
More Details
4.7
EV/S
EV/S
Enterprise Value to Sales
4.7
vs History
98
vs Industry
25
Median 3Y
11.8
Median 5Y
13.7
Industry
2.5
Forward
4.5
More Details
8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8
vs History
98
vs Industry
28
Median 3Y
19.9
Median 5Y
23.6
Industry
5.2
More Details
14.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.6
vs History
98
vs Industry
24
Median 3Y
29
Median 5Y
39.8
Industry
12.5
Forward
13.7
More Details
16.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.4
vs History
98
vs Industry
28
Median 3Y
32
Median 5Y
43.2
Industry
17.2
More Details
18.6
EV/OCF
EV/OCF
Enterprise Value to OCF
18.6
vs History
98
vs Industry
24
Median 3Y
45.8
Median 5Y
69.2
Industry
15.1
More Details
23
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23
vs History
98
vs Industry
22
Median 3Y
49.2
Median 5Y
74.9
Industry
19.7
More Details
4.3
EV/IC
EV/IC
Enterprise Value to IC
4.3
vs History
98
vs Industry
20
Median 3Y
13.1
Median 5Y
15.3
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
M3 Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
M3 Inc
TSE:2413
1.3T JPY 5.4 27.5 14.6 16.4
US
Veeva Systems Inc
NYSE:VEEV
32.4B USD 13.7 61.6 61.4 66.1
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.7B AUD 78.1 163.9 112.7 112.7
US
Inspire Medical Systems Inc
NYSE:INSP
7B USD 11.2 -331.8 -175.3 -162.9
US
Doximity Inc
NYSE:DOCS
4.4B USD 9.5 32.2 21.5 22.9
SE
Sectra AB
STO:SECT B
42B SEK 25.7 99.1 -66.2 -66.2
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -22.1 26.1 277.7
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.8B USD 3.8 -319.5 34.1 -111.3
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
P/E Multiple
Earnings Growth
JP
M3 Inc
TSE:2413
Average P/E: 71.9
27.5
26%
US
Veeva Systems Inc
NYSE:VEEV
61.6
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
163.9
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -331.8 N/A
US
Doximity Inc
NYSE:DOCS
32.2
79%
SE
Sectra AB
STO:SECT B
99.1
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -22.1 N/A
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -319.5 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
EV/EBIT Multiple
EBIT Growth
JP
M3 Inc
TSE:2413
Average EV/EBIT: 609.9
16.4
N/A
US
Veeva Systems Inc
NYSE:VEEV
66.1
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
112.7
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -162.9 N/A
US
Doximity Inc
NYSE:DOCS
22.9
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.2 N/A
US
Evolent Health Inc
NYSE:EVH
277.7
2 086%
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -111.3 N/A
US
Vocera Communications Inc
NYSE:VCRA
4 233.4
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.